Simplicity Wealth’s Gilead Sciences GILD Stock Holding History

Simplicity Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Sell	7,914 -707	-8%	-$99K	0.06%	277
2025 Q4	$1.06M	Buy	8,621 +142	+2%	+$17.3K	0.06%	268
2025 Q3	$941K	Sell	8,479 -2,629	-24%	-$299K	0.05%	307
2025 Q2	$1.23M	Buy	11,108 +6,802	+158%	+$724K	0.05%	293
2025 Q1	$483K	Buy	+4,306	New	+$444K	0.04%	346
2024 Q3	–	Sell	-21,064	Closed	-$1.45M	–	764
2024 Q2	$1.45M	Sell	21,064 -763	-3%	-$50.9K	0.03%	425
2024 Q1	$1.6M	Buy	+21,827	New	+$1.68M	0.04%	397

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Simplicity Wealth's GILD Position: Q1 2026 in Review

Simplicity Wealth reduced its Gilead Sciences (GILD) stake by 8.2% in Q1 2026, selling an estimated $99K and leaving 7,914 shares worth $1.1M. The position accounts for 0.06% of the portfolio, ranked #277.

Simplicity Wealth first reported a position in GILD in Q1 2024 and has held it in 7 quarters since. The position peaked at $1.6M in Q1 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Simplicity Wealth held 7,914 shares of Gilead Sciences worth $1.1M as of Q1 2026.
Simplicity Wealth sold 707 Gilead Sciences shares in Q1 2026, an estimated $99K.
Gilead Sciences made up 0.06% of Simplicity Wealth's portfolio in Q1 2026, its #277 holding.
Simplicity Wealth first reported a position in Gilead Sciences in Q1 2024 and has held it in 7 quarters since.
Simplicity Wealth's Gilead Sciences position peaked at $1.6M in Q1 2024.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Simplicity Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.